Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BACH2-driven tissue resident memory programs promote HIV-1 persistence.
Wei Y, Ma HK, Wong ME, Papasavvas E, Konnikova L, Tebas P, Morgenstern R, Montaner LJ, Ho YC. Wei Y, et al. Among authors: papasavvas e. bioRxiv [Preprint]. 2024 Dec 20:2024.12.16.628794. doi: 10.1101/2024.12.16.628794. bioRxiv. 2024. PMID: 39763845 Free PMC article. Preprint.
Cloning and functional characterization of novel human neutralizing anti-interferon-alpha and anti-interferon-beta antibodies.
Papasavvas E, Lu L, Fair M, Oliva I, Cassel J, Majumdar S, Mounzer K, Kostman JR, Tebas P, Bar-Or A, Muthumani K, Montaner LJ. Papasavvas E, et al. bioRxiv [Preprint]. 2024 May 5:2024.05.05.591636. doi: 10.1101/2024.05.05.591636. bioRxiv. 2024. Update in: J Immunol. 2024 Sep 15;213(6):808-822. doi: 10.4049/jimmunol.2400265 PMID: 38746170 Free PMC article. Updated. Preprint.
Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial.
Papasavvas E, Azzoni L, Pagliuzza A, Abdel-Mohsen M, Ross BN, Fair M, Howell BJ, Hazuda DJ, Chomont N, Li Q, Mounzer K, Kostman JR, Tebas P, Montaner LJ. Papasavvas E, et al. AIDS Res Hum Retroviruses. 2021 Jun;37(6):433-443. doi: 10.1089/AID.2020.0243. Epub 2021 Jan 29. AIDS Res Hum Retroviruses. 2021. PMID: 33323024 Free PMC article. Clinical Trial.
Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.
Vadrevu SK, Trbojevic-Akmacic I, Kossenkov AV, Colomb F, Giron LB, Anzurez A, Lynn K, Mounzer K, Landay AL, Kaplan RC, Papasavvas E, Montaner LJ, Lauc G, Abdel-Mohsen M. Vadrevu SK, et al. Among authors: papasavvas e. J Leukoc Biol. 2018 Sep;104(3):461-471. doi: 10.1002/JLB.3HI1217-500R. Epub 2018 Apr 6. J Leukoc Biol. 2018. PMID: 29633346 Free PMC article.
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.
Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, Busch MP, Deeks SG, Carrington M, O'Doherty U, Kostman J, Montaner LJ. Azzoni L, et al. Among authors: papasavvas e. J Infect Dis. 2013 Jan 15;207(2):213-22. doi: 10.1093/infdis/jis663. Epub 2012 Oct 26. J Infect Dis. 2013. PMID: 23105144 Free PMC article. Clinical Trial.
Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling.
Colomb F, Giron LB, Premeaux TA, Mitchell BI, Niki T, Papasavvas E, Montaner LJ, Ndhlovu LC, Abdel-Mohsen M. Colomb F, et al. Among authors: papasavvas e. Front Immunol. 2019 Feb 20;10:267. doi: 10.3389/fimmu.2019.00267. eCollection 2019. Front Immunol. 2019. PMID: 30842775 Free PMC article.
Interferon-α alters host glycosylation machinery during treated HIV infection.
Giron LB, Colomb F, Papasavvas E, Azzoni L, Yin X, Fair M, Anzurez A, Damra M, Mounzer K, Kostman JR, Tebas P, O'Doherty U, Tateno H, Liu Q, Betts MR, Montaner LJ, Abdel-Mohsen M. Giron LB, et al. Among authors: papasavvas e. EBioMedicine. 2020 Sep;59:102945. doi: 10.1016/j.ebiom.2020.102945. Epub 2020 Aug 19. EBioMedicine. 2020. PMID: 32827942 Free PMC article.
65 results